“Researchers have found that a suite of complementary tests can quantify changes in dogs suspected of suffering from cognitive decline. The approach could not only aid owners in managing their elderly canine’s care, but could also serve as a model for evaluating cognitive decline progression in — and treatments for — humans with Alzheimer’s disease.”
–
Backstory
Canine cognitive dysfunction syndrome (CCDS) is similar to Alzheimer’s disease in humans in that cognitive decline is associated with the development of amyloid plaques as well as cortical atrophy, a progressive degeneration of brain tissue. CCDS is also challenging to diagnose. Traditionally, CCDS is diagnosed based on ruling out any obvious physical conditions and an owner’s answers to a questionnaire. But the current method of diagnosing CCDS is problematic because there may be other factors at play that give the appearance of cognitive decline. Researchers set out to uncover and compile a series…
View original post 256 more words
"OUR WORLD" 